Trial no.:
|
PACTR201801002953256 |
Date of Approval:
|
09/01/2018 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
use of clomid in control of DMPA bleeding |
Official scientific title |
Clomiphene citrate as a new modality in management of bleeding with depomedroxyprogesterone acetate (DMPA) |
Brief summary describing the background
and objectives of the trial
|
DMPA causes irregular uterine bleeding due to unknown cause mostly due to endometrial atrophy. clomiphene citrate, CC, could be used to control such bleeding
the objective is to asses the effectiveness of CC to stop bleeding in DMPA compared to placebo |
Type of trial |
CCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
contraceptive bleeding,Obstetrics and Gynecology |
Sub-Disease(s) or condition(s) being studied |
Fertility-female |
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/01/2017 |
Actual trial start date |
01/01/2017 |
Anticipated date of last follow up |
30/08/2017 |
Actual Last follow-up date |
30/08/2017 |
Anticipated target sample size (number of participants) |
250 |
Actual target sample size (number of participants) |
200 |
Recruitment status |
Stopped early/ terminated |
Publication URL |
|
|